MannKind Corporation (MNKD) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1 CASPER STREET DANBURY, CT 06810 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 197,256 | 251,588 | 247,761 | 300,729 | 295,099 | 141,016 | |||
| Cash and cash equivalent | 46,339 | 62,373 | 96,643 | 193,272 | 238,480 | 83,016 | |||
| Short-term investments | 150,917 | 189,215 | 151,118 | 107,457 | 56,619 | 58,000 | |||
| Restricted cash and investments | 732 | ||||||||
| Receivables | 11,804 | 18,184 | 23,346 | 19,912 | 14,901 | 21,822 | |||
| Inventory, net of allowances, customer advances and progress billings | 27,886 | 26,663 | 24,753 | 26,442 | 28,545 | 27,117 | |||
| Inventory | 27,886 | 26,663 | 24,753 | 26,442 | 28,545 | 27,117 | |||
| Other undisclosed current assets | 31,360 | 31,229 | 29,348 | 36,019 | 34,848 | 35,620 | |||
| Total current assets: | 268,306 | 327,664 | 325,940 | 383,102 | 373,393 | 225,575 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 222 | ||||||||
| Operating lease, right-of-use asset | 4,073 | ||||||||
| Property, plant and equipment | 85,365 | 85,339 | 85,144 | 83,620 | 84,220 | 80,411 | |||
| Long-term investments and receivables | 5,482 | 16,796 | 13,398 | 3,726 | 7,155 | 3,271 | |||
| Long-term investments | 5,482 | 16,796 | 13,398 | 3,726 | 7,155 | 3,271 | |||
| Intangible assets, net (including goodwill) | 7,196 | 7,244 | 2,964 | 2,984 | 3,004 | 3,024 | |||
| Goodwill | 1,931 | 1,931 | 1,931 | 1,931 | 1,931 | 1,931 | |||
| Intangible assets, net (excluding goodwill) | 5,265 | 5,313 | 1,033 | 1,053 | 1,073 | 1,093 | |||
| Other noncurrent assets | 26,757 | 26,422 | 15,658 | 7,447 | 7,426 | 8,047 | |||
| Other undisclosed noncurrent assets | 737 | 735 | (3,563) | ||||||
| Total noncurrent assets: | 125,537 | 136,536 | 117,896 | 97,777 | 101,805 | 94,753 | |||
| TOTAL ASSETS: | 393,843 | 464,200 | 443,836 | 480,879 | 475,198 | 320,328 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 47,085 | 43,830 | 50,508 | 49,440 | 51,616 | 48,852 | |||
| Accounts payable | 6,792 | 6,444 | 9,556 | 7,149 | 9,580 | 16,754 | |||
| Accrued liabilities | 40,293 | 37,386 | 40,952 | 42,291 | 42,036 | 32,098 | |||
| Deferred revenue | 12,407 | 6,518 | 7,420 | 7,601 | 9,085 | 3,670 | |||
| Debt | 52 | 39 | 9,872 | 9,809 | 9,747 | ||||
| Other undisclosed current liabilities | 22,345 | 21,701 | 22,045 | 32,983 | 33,615 | 34,105 | |||
| Total current liabilities: | 81,837 | 72,101 | 80,012 | 99,896 | 104,125 | 96,374 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 36,051 | 228,112 | 227,761 | 321,421 | 321,170 | 320,862 | |||
| Long-term debt, excluding current maturities | 36,051 | 227,941 | 227,577 | 227,214 | 226,851 | 226,487 | |||
| Finance lease, liability | 171 | 184 | 94,207 | 94,319 | 94,375 | ||||
| Liabilities, other than long-term debt | 62,805 | 77,317 | 69,388 | 71,386 | 73,719 | 73,758 | |||
| Deferred revenue | 51,160 | 65,150 | 66,116 | 67,741 | 69,794 | 69,469 | |||
| Operating lease, liability | 11,645 | 12,167 | 3,272 | 3,645 | 3,925 | 4,289 | |||
| Other undisclosed noncurrent liabilities | 291,966 | 296,596 | 292,455 | 218,146 | 222,352 | 81,113 | |||
| Total noncurrent liabilities: | 390,822 | 602,025 | 589,604 | 610,953 | 617,241 | 475,733 | |||
| Total liabilities: | 472,659 | 674,126 | 669,616 | 710,849 | 721,366 | 572,107 | |||
| Equity | |||||||||
| Equity, attributable to parent | (78,816) | (209,926) | (225,780) | (229,970) | (246,168) | (251,779) | |||
| Common stock | 3,029 | 2,753 | 2,740 | 2,703 | 2,700 | 2,695 | |||
| Additional paid in capital | 3,118,865 | 2,995,974 | 2,992,271 | 2,986,104 | 2,980,539 | 2,975,891 | |||
| Accumulated other comprehensive income | 1,109 | 588 | 443 | ||||||
| Accumulated deficit | (3,201,819) | (3,209,241) | (3,220,791) | (3,218,777) | (3,229,407) | (3,230,808) | |||
| Total equity: | (78,816) | (209,926) | (225,780) | (229,970) | (246,168) | (251,779) | |||
| TOTAL LIABILITIES AND EQUITY: | 393,843 | 464,200 | 443,836 | 480,879 | 475,198 | 320,328 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 76,776 | 70,079 | 72,386 | 66,263 | 58,472 | 51,253 | ||
| Cost of revenue | (30,677) | (39,296) | (35,399) | (30,943) | (32,547) | (31,902) | ||
| Cost of product and service sold | (4,808) | (3,197) | (5,605) | (3,819) | (6,114) | (3,995) | ||
| Gross profit: | 46,099 | 30,783 | 36,987 | 35,320 | 25,925 | 19,351 | ||
| Operating expenses | (19,604) | (18,023) | (20,377) | (18,598) | (18,067) | (14,254) | ||
| Operating income: | 26,495 | 12,760 | 16,610 | 16,722 | 7,858 | 5,097 | ||
| Nonoperating income (expense) | (18,050) | 110 | (18,301) | (5,828) | (4,896) | (3,376) | ||
| Investment income, nonoperating | 2,825 | 8,438 | 3,177 | 3,434 | 1,725 | 1,580 | ||
| Other nonoperating income (expense) | 32 | (164) | 318 | |||||
| Interest and debt expense | (13,394) | (1,801) | (7,050) | (2,567) | (2,677) | (2,815) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (4,949) | 11,069 | (8,741) | 8,327 | 285 | (1,094) | ||
| Other undisclosed income from continuing operations before income taxes | 13,394 | 1,801 | 7,050 | 2,567 | 2,677 | 2,815 | ||
| Income (loss) from continuing operations before income taxes: | 8,445 | 12,870 | (1,691) | 10,894 | 2,962 | 1,721 | ||
| Income tax expense | (1,023) | (1,320) | (323) | (264) | ||||
| Other undisclosed loss from continuing operations | (1,561) | |||||||
| Net income (loss) available to common stockholders, diluted: | 7,422 | 11,550 | (2,014) | 10,630 | 1,401 | 1,721 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 7,422 | 11,550 | (2,014) | 10,630 | 1,401 | 1,721 | ||
| Comprehensive income (loss): | 7,422 | 11,550 | (2,014) | 10,630 | 1,401 | 1,721 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 521 | 588 | (443) | |||||
| Comprehensive income (loss), net of tax, attributable to parent: | 7,943 | 12,138 | (2,014) | 10,630 | 958 | 1,721 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.